In short
- The gland that is removed does not grow back. What is excised does not regenerate.
- Fat does come back if weight is gained, and it is the commonest reason for an operated chest to change over the years.
- The longest published follow-up —10 to 19 years— found recurrence in 12.5% of glandular gynaecomastia against 62.5% of the predominantly fatty kind.
- Residual tissue is not recurrence: the first was there from the start and shows as soon as the swelling goes down; the second appears over time.
- Keeping the cause going —anabolic steroids, an untreated hormonal disorder— can indeed produce a fresh gynaecomastia.
- The most effective way of making the result last is the dullest one: a stable weight.
The useful answer separates two things that are confused all the time. The glandular tissue that is removed does not grow back: no organ capable of regenerating is left behind. Fat can come back, because the fat of the chest behaves like the fat everywhere else and responds to weight.
That means that when someone says “it has come back”, they are most likely pointing at one of these three things, and none of them is the same: fat that has returned with the kilos, glandular tissue that was never removed, or a fresh gynaecomastia caused by something that is still active.
This page sets out one specific question from the general guide to gynaecomastia: what happens in the long run after surgery.
Recurrence and residual tissue are not the same thing
It is the distinction that orders everything else, and often it is not even raised.
- Residual tissue is gland that was not removed. It has not grown: it was there from the operating theatre onwards. It becomes obvious when the swelling goes down, in the first few months, and it is usually felt as a persistent firmness under the areola or as an asymmetry between the two sides.
- Recurrence is new volume, appearing some time later in an area that had been left clear.
The difference matters because the solution is different and so is the moment of detecting it. In a cohort of 145 young patients, residual tissue was the commonest problem, at 12.6% of the breasts, followed by contour irregularities. Neither of those two things is a recurrence, even if the patient experiences them the same way.
What the longest published follow-up says
Here there is a figure that changes the conversation, and it is worth telling with its limits.
A German study called back for review, between 10 and 19 years after surgery (a mean of 13.8 years), patients operated on for gynaecomastia. Of the 41 invited, 16 came for examination: half had been operated on for glandular gynaecomastia and the other half for a predominantly fatty one.
The result was very lopsided:
- Glandular gynaecomastia: 1 in 8 with recurrence (12.5%).
- Predominantly fatty gynaecomastia: 5 in 8 with recurrence (62.5%).
That is, what comes back is above all the fatty component, and the difference between the two groups was statistically significant. The authors also found that the younger patients were more satisfied, especially as regards the improvement in self-esteem.
⚠️ How this has to be read. It is the longest published follow-up, and that is why it is worth citing, but it is 16 patients out of the 41 invited: a small sample with a great deal of loss to follow-up, and level of evidence IV. The direction of the finding is solid and matches what is seen in the clinic; the exact figure should not be taken as a personal probability.
Why fat comes back and the gland does not
The male breast gland is a remnant of tissue that proliferates under a hormonal stimulus. When it is removed, no structure capable of growing again is left: it does not regenerate the way skin or the liver does. That is why excision, properly done, is definitive as regards that component.
Fat is another matter. The fat cells left in the chest —and some are always left, because it is not suctioned down to skin on muscle— grow larger when weight is gained, just as in the abdomen or the back. They are not new cells: they are the same ones, fuller.
Hence the lopsidedness of the study above. And hence, too, the one recommendation that really protects the long-term result.
What really makes it come back
In order of how often it really happens:
- Gaining weight. It is, by a long way, the commonest reason for an operated chest to change over the years.
- Carrying on with anabolic steroids. Having surgery and continuing with the cycles is the most direct route to the problem reappearing; the stimulus that caused it is still active. In a prospective study the real level of use among patients who had had surgery was 39.2%, against the 4.1% recorded before surgery.
- An untreated cause. A hormonal, liver or thyroid disorder that is still there can stimulate the tissue that remains.
- Starting an associated medication. It is less common, but it is worth bearing in mind if volume appears years later with no change in weight.
When to suspect it is residual and not recurrence
Four signs that point the way, and that are worth taking to the review:
- The timing. If it was already noticeable in the first few months, as soon as the swelling went down, it points to residual tissue. If it appeared years later, to recurrence.
- The consistency. A defined firmness under the areola is more consistent with gland that was left; a soft, spread-out increase, with fat.
- The relationship with weight. If it has tracked the kilos, it is fat.
- The symmetry. Residual tissue is usually asymmetrical: one side more than the other.
What is done if it comes back
It depends on what it is, and that is why the first thing is to examine it, not to operate on it:
- If it is fat, the first thing is the weight. Liposuction on a chest that is still gaining kilos repeats the problem.
- If it is residual tissue, a revision is considered. It is usually a smaller operation than the first, through the same scar.
- If it is a fresh gynaecomastia from an active cause, the cause is treated before anything else is considered: the European guidelines recommend watchful waiting once the substance has been stopped or the underlying disease treated.
On revision, one honest figure is called for: the published reoperation rates vary enormously between series. A systematic review of 18 studies found reoperation rates of between 0.6% and 25%, with the express warning that only 2 of those 18 pieces of work were of good methodological quality. In the ten-year series we use as a reference across the rest of the cluster, revision was 4.8%.
Book an appointment
You can book your own appointment. Pick the day and time from the free slots in the diary, in a panel that opens right here, without leaving this page.
Frequently asked questions
Can gynaecomastia come back after surgery?
The glandular tissue removed does not grow back. What can reappear is the fatty component if weight is gained, and that is the commonest reason for an operated chest to change over the years. New volume can also appear if the cause is kept going: anabolic steroids or an untreated hormonal disorder.
I have had surgery and I can still feel a lump — does that mean it has come back?
If it has been noticeable since the first few months, it is most likely residual tissue —gland that was not removed— and not a recurrence. It is the commonest problem after this surgery and it is resolved by having it assessed at a review, not by waiting.
If I put on weight, will it go back to how it was?
The fatty component of the chest can increase, as it increases everywhere else. What does not come back is the gland. Long-term follow-up shows recurrences clearly commoner in predominantly fatty gynaecomastia than in glandular cases.
Can I go back to taking anabolic steroids after surgery?
It is the most direct route to the problem reappearing, because the stimulus that caused it becomes active again. It is a conversation worth having at the consultation and without evasions, before surgery and not afterwards.
How long does the final result take to show?
Months. The swelling goes down in stages and the internal scar goes on maturing after the chest already looks normal. Judging a possible recurrence before that point leads to the wrong conclusions.
If it comes back, does it all have to be done again from scratch?
It usually does not. If it is residual tissue, the revision is normally a smaller operation than the first and is done through the same scar. If it is fat, the first thing is to stabilise the weight.
Sources
- Fricke A, Lehner GM, Stark GB, Penna V. Long-Term Follow-up of Recurrence and Patient Satisfaction After Surgical Treatment of Gynecomastia. Aesthetic Plast Surg. 2017;41(3):491-498. PMID 28280898 — follow-up of 10 to 19 years (mean 13.8) on 16 patients examined out of 41 invited: recurrence in 12.5% of glandular gynaecomastia against 62.5% of the predominantly fatty kind, with a statistically significant difference; greater satisfaction and improvement in self-esteem in the younger patients. Level of evidence IV.
- McNamara CT, Nuzzi LC, Firriolo JM, et al. Complications and Quality of Life following Gynecomastia Correction in Adolescents and Young Men. Plast Reconstr Surg. 2022;149(6):1062e-1070e. PMID 35349529 — 145 patients: residual tissue was the commonest problem, at 12.6% of the breasts, followed by contour irregularities.
- Prasetyono TOH, Budhipramono AG, Andromeda I. Liposuction Assisted Gynecomastia Surgery With Minimal Periareolar Incision: a Systematic Review. Aesthetic Plast Surg. 2022;46(1):123-131. PMID 34379157 — systematic review of 18 studies: reoperation rates between 0.6% and 25% and complication rates between 0.06% and 26.67%, with only 2 of the 18 pieces of work considered to be of good methodological quality.
- Li CC, Fu JP, Chang SC, Chen TM, Chen SG. Surgical treatment of gynecomastia: complications and outcomes. Ann Plast Surg. 2012;69(5):510-515. PMID 21712702 — a ten-year series: an overall surgical revision rate of 4.8%.
- Beniwal M, Singh K, Singh P, Sharma A, Beniwal S. The Burden of Anabolic Androgenic Steroid-Induced Gynecomastia. Indian J Plast Surg. 2023;56(4):338-343. PMID 37705825 — the real level of anabolic steroid use among patients who had surgery was 39.19% against the 4.05% recorded before surgery; it recommends careful excision precisely in order to minimise recurrence.
- Kanakis GA, Nordkap L, Bang AK, et al. EAA clinical practice guidelines—gynecomastia evaluation and management. Andrology. 2019;7(6):778-793. PMID 31099174 — watchful waiting once the underlying disease has been treated or the associated substance stopped.
Sources checked one by one against PubMed on 12 August 2026.
Book your consultation
If you have had surgery and notice something that does not fit, what settles the question is an examination: telling whether it is residual tissue, fat that has come back or a fresh gynaecomastia completely changes what has to be done. At the Instituto de Cirugía Plástica del Mediterráneo, in Valencia, we also assess the results of operations carried out at other centres.
—
Clinical confirmation by the surgeon
Awaiting signature.
Educational content reviewed by Dr Alessandro Thione, registration no. 46/4621959, and Dr Alberto Ruiz Cases, registration no. 46/4624050, specialists in Plastic, Aesthetic and Reconstructive Surgery. The recurrence figures come from published series and do not constitute an individual probability; assessing a particular case requires an examination in person.
Registration no. 46/4621959
Registration no. 46/4624050
Last reviewed: 6 September 2026. This content is for information only and does not replace an individual assessment by a healthcare professional.
